CELLINK has announced the BIO X6 — a six-printhead bioprinting platform that enables users to combine several materials, cells and tools.
Researchers have transformed proteins and antibodies into stable, highly functional drug transporters with which tumour cells can be detected and killed.
Using Lego-like replaceable drug cartridges and Bluetooth Low Energy, the device can target specific neurons of interest using drugs and light for prolonged periods.
Farmers on mainland South Australia will be given the choice to plant genetically modified (GM) food crops next season.
Researchers have produced a compound with anticancer properties directly from the flowering garden plant known as feverfew, which is grown in many UK gardens.
Developer PDG will build laboratories and offices to house CSL's global corporate headquarters in the heart of the Melbourne Biomedical Precinct on Elizabeth St, Parkville.
The University of Technology Sydney (UTS) has opened the doors of its new Biologics Innovation Facility — a training and production facility that seeks to enable new biotech discoveries as well as to drive the jobs of the future.
MGC Pharmaceuticals has announced preclinical research highlighting the positive impact of using specific cannabinoid formulations in the treatment of glioblastoma.
Natural antibiotics may be more effective than their synthetic counterparts at remaining effective in the wake of antibiotic resistance — although that doesn't mean they can't be given a helping hand.
A human pancreas-on-a-chip, featuring bioengineered human pancreatic organoids, is helping scientists to identify the possible cause of cystic fibrosis-related diabetes.
So-called cannabinoid agonist medication could help tackle dependency on cannabis — a leading cause of drug treatment episodes in Australia.
Using a combination of long-acting drug treatment and gene editing, US researchers claim to have eliminated replication-competent HIV-1 DNA — the virus responsible for AIDS — from the genomes of living animals.
Scientists have discovered that repurposing a heart drug could significantly increase the survival rate for children with ependymoma — a particularly aggressive type of brain tumour.
Polyacrylate hydrogels create the support and microenvironment necessary for the growth and maintenance of cartilage cells, and could be optimal candidates for use in clinical practice.
Two years after the world's first comparative trial of mass drug administration against scabies, the infection rate remained significantly down.